Q4 2024 Earnings Call Transcript March 20, 2025 ARS Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.52, ...

So far, 2025 hasn't been the best year for stocks. Investors are understandably jittery and on the sidelines with on-again, off-again policy changes, trade wars, broken alliances, and interest rate ...

An in-depth analysis of recent analyst actions unveils how financial experts perceive CVS Health. The following summary ...

Good day, and welcome to ARS Pharmaceuticals fourth quarter and full year 2024 financial results conference call. (Operator Instructions) As a reminder, this call is being recorded. I would now like ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

The PBM plans to stop requiring coverage reauthorization for about 80 drugs, including Vertex’s cystic fibrosis medicines and ...

The massive pharmacy benefit manager plans to stop requiring coverage reauthorizations for roughly 80 drugs used to treat ...

A sign posted recently on the CVS Pharmacy and store at 3890 Phelan Blvd. states it will close on April 10. The notice did ...

Deep-pocketed investors have adopted a bearish approach towards CVS Health (NYSE:CVS), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...

LIVE ALONG HOLLINS FERRY ROAD WITH MORE. KATE. THE CVS BEHIND US HERE IS CLOSING MARCH 6TH. A CVS SPOKESPERSON CONFIRMED TO US TODAY, THOUGH SHE DECLINED TO TELL US THE SPECIFIC REASONS WHY.

CVS is looking to grow itself by shrinking. The pharmacy chain is opening around a dozen stores this year that are about the half the size of its traditional layout and have only a pharmacy ...

Its main brands include CVS Pharmacy, a retail drugstore chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider.